日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CAR-T manufacturing reduces heterogeneity between CIDP and multiple myeloma patient-derived T cells.

CAR-T 细胞制造技术降低了 CIDP 和多发性骨髓瘤患者来源 T 细胞之间的异质性。

Wang Xu, Wang Pu, Zhou Qi, Wei Xianzheng, Jin Yuhang, Liao Ying, Zhao Xuan, Hou Rui, Li Sijin, Guan Zhangchun, Ma Wen, Liu Dan, Shi Ming

Advances in CAR optimization strategies based on CD28

基于CD28的CAR优化策略的进展

Li, Sijin; Zhou, Yusi; Wang, Hairong; Qu, Gexi; Zhao, Xuan; Wang, Xu; Hou, Rui; Guan, Zhangchun; Liu, Dan; Zheng, Junnian; Shi, Ming

Nuclear PD-L1 drives IFN-γ-promoted lung metastasis of triple-negative breast cancer via POLR2A-mediated transcriptional activation of LY6E.

核PD-L1通过POLR2A介导的LY6E转录激活,驱动IFN-γ促进的三阴性乳腺癌肺转移。

Wang Xu, Zhou Qi, Wang Pu, Bao Shunshun, Wei Xianzheng, Zhao Xuan, Hou Rui, Li Sijin, Guan Zhangchun, Ma Wen, Zheng Junnian, Liu Dan, Shi Ming

EF1α, rather than CMV promoter, is suitable for luciferase tag expression in target cells for in vitro cytotoxicity assays of CAR-T cells.

EF1α(而非 CMV 启动子)适用于在靶细胞中表达荧光素酶标签,用于 CAR-T 细胞的体外细胞毒性试验

Hou Rui, Zhang Zejun, Li Huan, He Wenyin, Wang Xu, Zhao Xuan, Li Sijin, Guan Zhangchun, Liu Dan, Zheng Junnian, Shi Ming

A new perspective on the therapeutic potential of tumor metastasis: targeting the metabolic interactions between TAMs and tumor cells

肿瘤转移治疗潜力的新视角:靶向肿瘤相关巨噬细胞(TAMs)与肿瘤细胞之间的代谢相互作用

Zhao, Xuan; Ren, Tong; Li, Sijin; Wang, Xu; Hou, Rui; Guan, Zhangchun; Liu, Dan; Zheng, Junnian; Shi, Ming

CRISPR screens in mechanism and target discovery for AML

CRISPR筛选在急性髓系白血病(AML)机制和靶点发现中的应用

Lin, Tian; Liu, Dan; Guan, Zhangchun; Zhao, Xuan; Li, Sijin; Wang, Xu; Hou, Rui; Zheng, Junnian; Cao, Jiang; Shi, Ming

Staphylococcus aureus β-Hemolysin Up-Regulates the Expression of IFN-γ by Human CD56(bright) NK Cells

金黄色葡萄球菌β-溶血素上调人CD56(bright) NK细胞中IFN-γ的表达

Guan, Zhangchun; Liu, Yu; Liu, Chenghua; Wang, Huiting; Feng, Jiannan; Yang, Guang